Spees LP, et al. - Among 999 stage IA-IVA cervical cancer patients, researchers investigated if geographic distance, a contributor to urban-rural health disparities, differentially impacted treatment initiation and completion among insured urban and rural patients. Initiation of guideline-concordant care within 6 weeks of diagnosis and, among stage IB2-IVA cancer patients, completion of concurrent chemoradiotherapy (CCRT) in 56 days, were considered as primary outcomes. They found that guideline-concordant care within 6 weeks of diagnosis was initiated in 48%, and of 492 stage IB2-IVA cancer patients, 37% completed CCRT in 56 days. Initiation of timely treatment was less likely reported in stage IA-IVA patients who lived ≥15 miles from the nearest treatment facility vs those <5 miles, in urban areas. Completion of CCRT in 56 days was more likely to be seen in rural women residing >15 miles from the nearest radiation facility among IB2-IVA stage cancer patients. Overall, the initiation and completion of treatment among urban and rural cervical cancer patients were differentially impacted by geographic distance.